A pair of Western-led lung imaging studies, including one performed in non-identical twin patients with lifelong asthma, have shown that airway defects in the lungs of asthmatic patients are like fingerprints –they have a unique pattern and maintain that pattern over time.
These studies deepen understanding of asthma and also open up opportunities for personalized therapies that can target specific areas of the lungs.
In a recent study published in the journal Radiology – Hyperpolarized Helium 3 MRI in Mild-to-Moderate Asthma: Prediction of Postbronchodilator Reversibility – researchers followed 11 patients with mild to moderate asthma over a six-year period. Using a specialized MRI technique developed at the Schulich School of Medicine & Dentistry, they were able to visualize where air travels in a patient’s lungs and, more importantly, where it does not.
These pockets of the lungs where there is no fresh air are called ventilation defects. Researchers and clinicians have long thought that these defects are random, widespread and change their location in the lungs depending on a number of factors in patients with asthma.
However, these studies refute that long-standing belief.
“Most of the patients in our study had essentially the same ventilation defects at the first visit and six years later both in terms of size and spatial location in the lungs,” said Rachel Eddy, a Schulich PhD Candidate and lead author on the studies. “This tells us that there are focal regions inside the lungs that are abnormal, and these stay that way over time.”
In a case study published today in the journal Chest – Nonidentical Twins With Asthma: Spatially Matched CT Airway and MRI Ventilation Abnormalities – researchers used the same technique in a set of twins with asthma. While the twins are non-identical, the findings showed they actually had identical ventilation defects in the same upper-left lung segment, which stayed the same over the duration of the seven-year study.
“The result in twins helps us further understand that asthma is not random, and asthma abnormalities persist over long periods of time in the same lung regions. The airway abnormalities likely have a heritable and environmental component,” Schulich professor Grace Parraga explained.
This finding emphasizes the importance of personalized and image-guided therapy for asthmatic patients.
“We see now that patients have different thumbprints of disease, and this points to the need for therapy that is patient-specific,” said Dr. Cory Yamashita, Associate Professor of Respirology at Schulich Medicine & Dentistry.
The researchers also looked at how the MRI airway defects predict those patients that transition from asthma to chronic obstructive pulmonary disease (COPD), which does not respond to treatments that help open up closed airways. This novel finding supports previous health-care database results and is critical because COPD patients experience constant and persistent shortness of breath and require more hospital-based care and much worse outcomes.
“COPD patients have a difficult-to-treat disease – experiencing life-altering acute worsening more frequently and requiring more frequent hospitalizations,” continued Parraga, Tier 1 Canada Research Chair Lung Imaging to Transform Outcomes and a scientist at Robarts Research Institute.
“If we can predict those that transition from asthma to COPD, perhaps we can find new ways to prevent this from happening in the first place. This would save countless health care dollars, decrease hospitalizations, and improve quality of life and disease control in patients.”
Both studies were funded through grants from the Canadian Institutes of Health Research.
